Electronic Logs - The next phase of execution maturity in pharma
Beyond Reporting - Safety surveillance analytics for medical devices...
Two Acts, One Geopolitical Moment
From Snapshots to Movies
Clinically Validated Probiotics
EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
MAb Aggregation: A Problem Within the Biopharmaceutical Industry
Associate Professor, Trinity College Dublin, Ireland
Educated at Seoul National University UC Berkeley and Purdue University with postdoctoral research at the University of Oxford KH Mok specializes in utilising biomolecular NMR spectroscopy to protein foldingmisfoldingaggregation research Coauthor of publications in Nature Nature Communications Nature Immunology PNAS and others he currently serves as a Eureka Independent Evaluation Panel member tec...
Articles
Emerging Technologies in Pharmaceutical Sciences
The pharmaceutical industry has always been defined by two constants the extraordinary complexity of what it does and the extraordinary cost of doing it Bringing a single drug from discovery to approval has historically taken to years and cost an average of US billion
Research Insights
Electrohydrodynamic encapsulation of cisplatin in poly (lactic-co-glycolic acid) nanoparticles for controlled drug delivery
Abstract Targeted delivery of potent toxic chemotherapy drugs such as cisplatin is a significant area of research in cancer treatment In this study cisplatin was successfully encapsulated with high efficiency in poly lacticcoglycolic acid polymeric nanoparticles by using electrohydrodynamic atomization EHDA where applied voltage and soluti
Case Studies
Case Study: A Simple And Sensitive Method To Analyze Genotoxic Impurityhydrazine In Pharmaceutical Materials
Abstract Hydrazine NH is a known genotoxic impurity that typically needs to be controlled down to low ppm level in pharmaceutical development Hydrazine however is a challenging molecule to analyze using conventional analytical techniques due to its physical and chemical properties eg lack of chromophore absence of any carbon atom low molecular weigh
Techno Trends
Stoke Therapeutics Introduced Breakthrough Zorevunersen for the Treatment of Dravet Syndrome
Stoke Therapeutics has introduced zorevunersen a groundbreaking treatment for Dravet syndrome targeting cases with confirmed SCNA gene mutations that are not associated with gainoffunction
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Endocrine Disrupting Compounds (EDCs)
Sintu Kumar Samanta has been working as an Assistant professor in IIIT Allahabad, India. He did Ph.D. and post-doctoral research from IIT Kharagpur and IISc Bangalore, India respectively. He is working in the area of Biochemistry and Nanobiotechnology. He published research work in several international journals and filed one Indian patent.
Pavan Kumar Gautamis presently working as a Post-Doctoral Fellow in the Department of Applied Sciences at IIIT Allahabad, India. He obtained Ph.D. from the University of Allahabad, India. His area of research is synthesis of nanoparticles for water remediation. He published his research work in many international journals.
Novel Developments in Drug Delivery Systems
Saina Bijanzadeh is a chemist specializing in nanomaterial-based drug delivery and biomedical applications. She has research experience in nanoparticle synthesis, MOF platforms, and drug release systems, with published work in international journals. Her interests focus on innovative therapeutic delivery strategies and interdisciplinary pharmaceutical and bio(medical)engineering research.
Biologics at Scale
Surbhi Gupta is an Industry Principal at Frost & Sullivan with extensive experience in global pharmaceutical and biotech market research and consulting. She leads the Personalized Therapeutics program, focusing on next-generation modalities and precision medicine. Her expertise spans market analytics, forecasting, and competitive benchmarking, supporting strategic decision-making for global clients. Recognised as a trusted growth advisor, helping stakeholders navigate disruption, accelerate innovation, and capture transformative growth opportunities across the evolving biopharma landscape.
Significance of Bioinformatics in Precision Oncology
Pravitha Kasu Sivanandan holds an MSc in Bioinformatics from Bharathiyar University, India, and works as a Bioinformatician at MVR Cancer Centre & Research Institute. She specializes in multi-omics data analysis, focusing on stratified healthcare. She focuses on potential of bioinformatics in precision oncology. Pravitha is also an Associate Member of AACR.
Labelling and imaging of Radiopharmaceuticals
Sumel Ashique has been working as an assistant professor in Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 50+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 4 granted patents from IP and Australia, 8 published book chapters in International Books and 12 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis. Currently he is editing 5 books under CRC; AAP, Springer and Wiley publisher
Radheshyam Pal is an Assistant Professor at Pandaveswar School of Pharmacy. His areas of expertise in Neuropharmacology. He specifically works on the role of natural products in the CNS. He has 2 years of teaching experience. He has 2 patents and also 10 book chapters submitted in international publisher.
press releasesRead more...
Foresee Pharmaceuticals Announces China NMPA Approval of CAMCEVI® 42 mg for the Treatment of Advanced Prostate Cancer; Changchun GeneScience Pharmaceutical will Commercialize in China
Foresee Pharmaceuticals announced that it was notified by its licensing partner Changchun GeneScience Pharmaceutical Co Ltd GenSci that Chinas National Medical Products Administration NMPA has approved the Marketing Authorization Application MAA for CAMCEVI mg a readytouse month subcutaneous depot...
Expert Shares How to Avoid Common Pitfalls in Preclinical Development
Behind every drug that reaches patients is a preclinical programme that most people never see Getting it right can be the difference between a molecule that moves smoothly into the clinic and one that stalls before it gets there Preclinical development brings together pharmacology toxicology formula...
BioAgilytix Expands Global Bioanalytical Capabilities with New Sydney Laboratory
BioAgilytix a global leader in bioanalytical services announces the opening of a new laboratory in North Ryde Sydney through biolabs its Australian laboratory business The expansion extends BioAgilytixs bioanalytical footprint across Australia Europe and the United States
Insitro Designed Machine Learning Models for Small Molecule in vivo Pharmacokinetic Behavior Prediction Now Available in Lilly TuneLab
Insitro the AI company unlocking causal human biology to systematically generate highimpact therapeutics today announced that the advanced machine learning models that insitro built with Eli Lilly
Lotus Pharmaceutical Announces Completion of UroVaxom® Product Rights Acquisition in South Korea
Lotus Pharmaceutical Co Ltd Taiwan Stock Exchange a global pharmaceutical company headquartered in Taiwan today announced the completion of the acquisition of the South Korea product rights
XtalPi Debuts Kodexia™, the World's First Closed-Loop siRNA Platform Combining Generative AI with First-Principles Modeling
XtalPi Holdings Limited HKEX an AI and roboticsdriven drug and materials discovery company today debuted Kodexia the industrys first closedloop small interfering RNA siRNA
EventsRead more...
14 - 15
Oct 2026PDA Aseptic Manufacturing Excellence Conference
Pullman East Melbourne, Austra...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
26 - 28
Oct 2026World Orphan Drug Congress
RAI, Amsterdam, Netherlands
27 - 28
Oct 2026PM& AC 2026
Novotel Hyderabad Convention C...
28 - 30
Oct 2026BIOPLUS-INTERPHEX KOREA 2026
COEX, Seoul
LATEST NEWSRead more...
InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in China
InnoCare Pharma a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases announced today that the Center for Drug Evaluation CDE of Chinas National Medical Products Administration NMPA has approved its Investigational New Drug IND application for ICPB a bispeci...
Mint Pharmaceuticals and Bayer Expand Medicine Distribution in Canada
Mint Pharmaceuticals and Bayer have expanded their distribution partnership in Canada to include several additional medicines across womens health cardiovascular care and anticoagulation
Halozyme Expands argenx Collaboration to Include Two Additional Development Targets
Halozyme Therapeutics has expanded its global collaboration and licence agreement with argenx to develop and commercialise subcutaneous formulations for two additional exclusive targets using its ENHANZE drug delivery technology
CSL and Alentis Partner to Advance Lixudebart for Rare Kidney and Liver Diseases
CSL and Alentis Therapeutics have entered into a global collaboration to jointly develop and commercialise lixudebart an investigational treatment that targets claudin and could have applications across several kidney liver and other diseases
Regeneron and Sanofi Expand Collaboration to Develop Long-Acting Immunology Antibodies
Regeneron Pharmaceuticals and Sanofi have expanded their longstanding antibody collaboration to develop and commercialise a new group of longacting immunology treatments
SK pharmteco Announces $200 Million Investment to Expand Manufacturing Capacity
SK pharmteco has announced a fiveyear investment of more than million to expand and upgrade its development and manufacturing capabilities in the US focusing on small molecules and peptides
